"By being a part of this membership, you get access to education, information, resources, [and] materials that are hopefully going to be helpful in the care of cancer patients," said Rick McDonough, MD, president of the Florida Society of Clinical Oncology (FLASCO).
"By being a part of this membership, you get access to education, information, resources, [and] materials that are hopefully going to be helpful in the care of cancer patients," said Rick McDonough, MD, president of the Florida Society of Clinical Oncology (FLASCO).
Transcript:What are the benefits of being a FLASCO member?
So, in talking about education and inclusiveness, the ability to connect to your peers and people in different disciplines that touch on cancer care [is vital]—collaboration is, I think, one of the key things in medical care. So, whether that’s on the small level of within an office of the team of people that are day by day helping you take care of cancer and blood cancer patients, or whether that is across the broader spectrum–whether that’s a group or a hospital system, whether that’s an academic medical center that you have a large group of people who are focused on the mission of that entity.
And so then, we’ve really sought to expand that further across the state so that we can bring together people from different geographies within the state, different settings and the way that they care for cancer patients, whether that’s a single doctor in a practice and their staff or whether that’s large institutions, whether that’s academic or even private practices that are large and spread across large areas of the state. So, by being a part of this membership, you get access to education, information, resources, [and] materials that are hopefully going to be helpful in the care of cancer patients, [and] make sure that in making those connections, the more that we all collaborate, the better that [we] can become.
And beyond that, listening to, for example, one of the fellows who was present for last night’s discussion, it was really eye opening particularly for people that are new in their career to be able to say, ‘This is information that I need to know,’ beyond just the scientific and the medical aspects of their training so that they can sort of understand more of the big picture of what’s involved and as this gets more and more complicated—and currently in oncology change is so rapid in both the science and the mechanism of how we deliver care–that we can be able to collaborate to make those advances and continue to move this forward.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More